A carregar...

Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges

The negative efficacy outcomes of double-blinded, randomized, placebo-controlled Phase III human clinical trials with selenomethionine (SeMet) and SeMet-rich selenized-yeast (Se-yeast) for prostate cancer prevention and Se-yeast for prevention of non-small cell lung cancer (NSCLC) in North America l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nutr Cancer
Main Authors: Lü, Junxuan, Zhang, Jinhui, Jiang, Cheng, Deng, Yibin, Özten, Nur, Bosland, Maarten C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4822195/
https://ncbi.nlm.nih.gov/pubmed/26595411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01635581.2016.1105267
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!